Gastric penetration of amoxicillin in a human Helicobacter pylori- infected xenograft model

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 8, 1999, Pages 1909-1913

  Lozniewski, Alain ^a,d   Duprez, Adrien ^b   Renault, Corinne ^c   Muhale, Filipe ^b   Conroy, Marie Christine ^a   Weber, Michele ^a   Le Faou, Alain ^a   Jehl, Francois ^c  

^a CNRS   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH; STOMACH MUCOSA; TISSUE DISTRIBUTION; XENOGRAFT;

EID: 0032819381     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.8.1909     Document Type: Article

References (37)

1. Bayerdorffer, E., and R. Ottenjann. 1988. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease. Scand. J. Gastroenterol. 23: 93-100.
2. Berry, V., K. Jennings, and G. Woodnutt. 1995. Bactericidal and morphological effects of amoxicillin on Helicobacter pylori. Antimicrob. Agents Chemother. 39:1859-1861.
3. Bode, G., P. Malfertheiner, and H. Ditschuneit. 1990. Pathogenetic implications of ultrastructural findings in Campylobacter pylori related gastroduodenal disease. Scand. J. Gastroenterol. 23(Suppl. 142):25-39.
4. Carbon, C. 1990. Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage. Eur. J. Clin. Microbiol. Infect. Dis. 9:510-516.
5. Cardaci, G., J. R. Lambert, R. G. King, N. Onishi, and P. Midolo. 1995. Reduced amoxicillin uptake into human gastric mucosa when gastric juice pH is high. Antimicrob. Agents Chemother. 39:2084-2087.
6. Croydon, E. A. P., and R. Sutherland. 1970. α-Amino-p-hydroxybenzylpenicillin: absorption and excretion in man. Antimicrob. Agents Chemother. 1:427-433.
7. Dore, M. P., A. Piana, M. Carta, A. Atzei, B. M. Are, I. Mura, G. Massarelli, A. Maida, A. R. Sepulveda, D. Y. Graham, and G. Realdi. 1998. Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 12:635-639.
8. Dunn, B. E., H. Cohen, and M. J. Blaser. 1997. Helicobacter pylori. Clin. Microbiol. Rev. 10:720-741.
9. Erah, P. O., A. F. Goddard, D. A. Barrett, P. N. Shaw, and R. C. Spiller. 1997. The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection. J. Antimicrob. Chemother. 39:5-12.
10. Glupczynski, Y., M. Labbe, A. Burette, M. Delmee, V. Avesani, and C. Bruck. 1987. Treatment failure of oftoxacin in Campylobacter pylori infection. Lancet i:1096.
11. Goddard, A. F., M. J. Jessa, D. A. Barrett, P. N. Shaw, C. Cederberg, and R. C. Spiller. 1996. Effect of omeprazole on the distribution of metronidazole, amoxicillin and clarithromycin in human gastric juice. Gastroenterology 111:358-367.
12. Goddard, A. F., and R. C. Spiller. 1997. In vitro assessment of gastric mucosal transfer of anti-Helicobacter therapeutic agents. Antimicrob. Agents Chemother. 41:1246-1249.
13. Gotoh, A., Y. Kawakami, T. Akahane, T. Akamatsu, T. Shimizu, K. Kiyosawa, and T. Katsuyama. 1997. Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy. Microbiol. Immunol. 41:7-12.
14. Guslandi, M., M. Sorghi, and A. Tittobello. 1994. Does Helicobacter pylori affect gastric microcirculation? Ital. J. Gastroenterol. 26:383-384.
15. Irie, Y., K. Tateda, T. Matsumoto, S. Miyazaki, and K. Yamaguchi. 1997. Antibiotic MICs and short time-killing against Helicobacter pylori: therapeutic potential of kanamycin. J. Antimicrob. Chemother. 40:235-240.
16. Jehl, F., C. Gallion, and H. Monteil. 1990. High-performance liquid chromatography of antibiotics. J. Chromatogr. 531:509-548.
17. Lozniewski, A., M. Weber, J. D. De Korwin, M. C. Conroy, P. Franck, J. Floquet, A. Le Faou, and J. C. Burdin. 1995. Use of cryomicrotomy to study gastric diffusion of amoxicillin in guinea pigs. Antimicrob. Agents Chemother. 39:766-768.
18. Lozniewski, A., J. D. De Korwin, F. Muhale, and F. Jehl. 1998. Gastric diffusion of antibiotics used against Helicobacter pylori. Int. J. Antimicrob. Agents 9:181-193.
19. Lozniewski, A., F. Muhale, R. Hatier, M. C. Conroy, A. Le Faou, M. Weber, and A. Duprez. 1999. Human embryonic gastric xenografts in nude mice: a new model of Helicobacter pylori infection. Infect. Immun. 67:1798-1805.
20. McNulty, C. A. M., J. C. Gearty, B. Crump, M. Davis, I. A. Donovan, V. Melikian, D. M. Lister, and R. Wise. 1986. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br. Med. J. 298:645-649.
21. McNulty, C. A. M., J. C. Dent, G. A. Ford, and S. P. Wilkinson. 1988. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J. Antimicrob. Chemother. 22:729-738.
22. Mégraud, F., P. Trimoulet, H. Lamouliatte, and L. Boyanova. 1991. Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells. Antimicrob. Agents Chemother. 35:869-872.
23. Midolo, P. D., J. D. Turnidge, and W. J. Munckhof. 1996. Is bactericidal activity of amoxicillin against Helicobacter pylori concentration dependent? Antimicrob. Agents Chemother. 40:1327-1328.
24. Midolo, P. D., J. D. Turnidge, and J. R. Lambert. 1997. Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro. J. Antimicrob. Chemother. 39:331-337.
25. Noach, L. A., T. M. Rolf, and G. N. J. Tylgat. 1994. Electron microscopy study of association between Helicobacter pylori and gastric and duodenal mucosa. J. Clin. Pathol. 47:699-704.
26. Penston, J. G., and K. E. L. McColl. 1997. Eradication of Helicobacter pylori: an objective assessment of current therapies. Br. J. Clin. Pharmacol. 43:223-243.
27. Peterson, W. L., D. Y. Graham, B. Marshall, M. J. Blaser, R. M. Genta, P. D. Klein, C. W. Stratton, J. Drnec, P. Prokocimer, and N. Siepman. 1993. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am. J. Gastroenterol. 88:1860-1864.
28. Pettoello-Mantovani, M., T. R. Kollmann, C. Raker, A. Kim, S. Yurasov, R. Tudor, H. Wilshire, and H. Goldstein. 1997. Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues. Antimicrob. Agents Chemother. 41:1880-1887.
29. Sarosiek, J., A. Slomiany, and B. L. Slomiany. 1988. Evidence for weakening of gastric mucus integrity by Campylobacter pylori. Scand. J. Gastroenterol. 23:585-590.
30. Sarosiek, J., B. J. Marshall, D. A. Peura, S. Hoffman, T. Feng, and R. W. McCallum. 1991. Gastroduodenal mucus gel thickness in patients with Helicobacter pylori: a method for assessment of biopsy specimens. Am. J. Gastroenterol. 86:729-734.
31. Sawada, Y., M. Hanano, Y. Sugiyama, and T. Iga. 1984. Prediction of the disposition of β-lactam antibiotics in humans from pharmacokinetic parameters in animals. J. Pharmacokinet. Biopharm. 12:241-261.
32. Stone, J. W., R. Wise, I. A. Donovan, and J. Gearty. 1988. Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach. J. Antimicrob. Chemother. 22:92-93.
33. Unge, P., and H. Gnarpe. 1988. Pharmacokinetic, bacteriological and clinical aspects of the use of doxycycline in patients with active duodenal ulcer associated with Campylobacter pylori. Scand. J. Infect. Dis. 53(Suppl):70-73.
34. Unge, P., A. Gad, H. Gnarpe, and J. Olsson. 1989. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? Scand. J. Gastroenterol. 24(Suppl.167):49-54.
35. Westblom, T. U., D. E. Duriex, E. Madan, and R. B. Belshe. 1990. Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens. Antimicrob. Agents Chemother. 34: 25-28.
36. 2-receptor antagonist. Dig. Dis. Sci. 36: 25-28.
37. Westblom, T. U., and D. E. Duriex. 1991. Pharmacokinetics of cefuroxime and ciprofloxacin in gastric mucosa: comparison to in vitro inhibitory concentrations against Helicobacter pylori. Microbiologica 14:37-43.